CSI Market
Sign In | Register

Alx Oncology Holdings Inc (ALXO) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ALXO Annual Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Alx Oncology Holdings Inc funds operations, investments, and shareholder returns.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-35.90
Depreciation & amortization0.44
Amortization of Other Assets0.13
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Impairment of Long-Lived Assets Held-for-use0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
Research and Development in Process0.00
Gain (Loss) on Disposition of Assets, Total-0.25
Share-based Compensation5.19
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt-0.90
Changes In Fair Value Of Compound Derivative Liability And Warrants-
Non Cash Lease Costs-
Operating Finance Lease Right Of Use Asset Amortization Expense0.39
Increase Decrease In Payable And Accrued Liabilities Due To Related Parties Current-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Due from Related Parties, Current, Total0.00
Increase (Decrease) in Accounts Payable-1.98
Increase (Decrease) in Other Accrued Liabilities-1.65
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.93
Other Working Capital-1.04
Other Noncash Income (Expense)0.00
Other net0.54
Payments for (Proceeds from) Other Operating Activities1.64
Discontinued operations0.00
Net Cash flow from Operating Activities-34.71
Investing Activities
Capital Expenditures-0.07
Sale of Capital Items0.04
Proceeds from Sale of Available-for-sale Securities, Debt31.75
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments-130.24
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire in Process Research and Development0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-0.19
Discontinued operations0.00
Net Cash Flow from Investing Activities-98.51
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-8.28
Long-term debt - borrowings7.39
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock150.79
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-10.17
Proceeds From Issuance Of Related Parties Convertible Preferred Stock-
Payment For Deferred Offering Costs-
Finance Lease Principal Payments-0.31
Noncash Or Part Noncash Acquisition Fixed Assets Acquired0.91
Right Of Use Asset Obtained In Exchange For Operating Lease Liability-
Receivables For Cash In Transit On Exercise Of Common Stock Under Equity Incentive Plans-
Proceeds From Equity Offerings Net Of Underwriter Discounts And Issuance Costs-
Payments Of Issuance Costs Related To Equity Offering-9.48
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities139.73
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-34.73
Total Cash Flow6.51
4 historic quarters locked

Sign in to unlock the full Alx Oncology Holdings Inc cash flow history.

Sign In Create Free Account

About Alx Oncology Holdings Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001193125-26-337920

Figures are derived from filed reports and may be restated. Historical data is subject to revision.